Finasteride: Not Guilty After All?

    October 2006 in “ The Lancet Oncology
    Tabitha M. Powledge
    TLDR Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.
    The 2003 trial of the 5α-reductase inhibitor finasteride demonstrated a nearly 25% reduction in prostate cancer risk compared to a placebo. However, this benefit was overshadowed by a 1.3% increase in the incidence of aggressive, high-grade prostate cancer among users. These mixed results led to a tempered enthusiasm for the drug despite its potential in reducing overall prostate cancer risk.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 3 years ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

      community I’m considering stopping finasteride

      in Finasteride/Dutasteride  155 upvotes 5 days ago
      The user is considering stopping finasteride due to depression, anxiety, and difficulty building muscle, despite its effectiveness in stopping hair loss. Suggestions include reducing the dose, switching to topical solutions, or consulting a doctor for alternatives like dutasteride or RU58841.

    Related Research

    3 / 3 results